Covovax

Serum Institute’s Covid-19 vaccine Covovax approved for children in the age group of 12 to 17 years

Covovax vaccination course consists of two separate doses of 0.5 ml each. After receiving one dose of the vaccine, the second dose should be administered after 3 weeks.

Serum Institute of India all set to manufacture Novavax’s COVID-19 vaccine Covovax, trial data demonstrates 90.4 overall efficacy

Adar Poonawalla, the CEO of SII, plans to launch Novavax's Covovax in India by September contingent upon the regulatory approvals